Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Eye cancer, Melanoma, Melanoma of the eye
Closed
Phase 2
This trial is looking at selumetinib and paclitaxel for a type of eye cancer called uveal melanoma. It is for people whose uveal melanoma has spread elsewhere in the body. This trial is supported by Cancer Research UK.
Recruitment start: 24 November 2015
Recruitment end: 28 November 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Paul Nathan
AstraZeneca
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University of Liverpool
This is Cancer Research UK trial number CRUK/13/033.
Last reviewed: 17 October 2022
CRUK internal database number: 11762
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
